SYSTEMS AND METHODS FOR TARGETED TISSUE TREATMENT
The invention generally relates to systems and methods for providing detection, identification, and precision targeting of specific tissue of interest to undergo a therapeutic treatment while minimizing or avoiding collateral damage to surrounding or adjacent non-targeted tissue.
1 . A system for treating a condition, the system comprising:
a treatment device including an end effector comprising one or more electrodes; and
a controller operably associated with the treatment device and configured to:
determine a treatment pattern for controlling delivery of energy from the one or more electrodes to one or more tissues at a target site based, at least in part, on identifying data received from the device associated with the one or more tissues;
receive and process real-time feedback data associated with the one or more tissues upon supplying treatment energy to the one or more electrodes; and
control supply of treatment energy to the one or more electrodes based on the processing of the real-time feedback data to ensure that the delivery of energy from the one or more electrodes is delivered at a level, and for a period of time, sufficient to ablate and/or modulate targeted tissue and minimize and/or prevent collateral damage to surrounding or adjacent non-targeted tissue at the target site.
2 . The system of claim 1 , wherein the identifying data is associated with one or more properties of the one or more tissues, the one or more properties comprising at least one of a type, a depth, and a location of each of the one or more tissues.
3 . The system of claim 2 , wherein a subset of the one or more electrodes is configured to deliver non-therapeutic stimulating energy at a frequency/waveform to respective positions at the target site to thereby sense at least bioelectric properties of the one or more tissues at the target site.
4 . The system of claim 3 , wherein the bioelectric properties comprise at least one of complex impedance, resistance, reactance, capacitance, inductance, permittivity, conductivity, dielectric properties, muscle or nerve firing voltage, muscle or nerve firing current, depolarization, hyperpolarization, magnetic field, and induced electromotive force.
5 . The system of claim 4 , wherein the controller is configured to process the identifying data to determine the treatment pattern.
6 . The system of claim 5 , wherein the processing of identifying data, via the controller, comprises comparing the identifying data received from the device with electric signature data associated with a plurality of known tissue types.
7 . The system of claim 6 , wherein the electric signature data comprises at least bioelectric properties of known tissue types.
8 . The system of claim 5 , wherein the comparison comprises correlating the identifying data received from the device with electric signature data from a supervised and/or an unsupervised trained neural network.
9 . The system of claim 1 , wherein the treatment pattern comprises at least one of a predetermined treatment time, a level of energy to be delivered from the electrodes, and a predetermined impedance threshold.
10 . The system of claim 9 , wherein the feedback data comprises at least impedance measurement data associated with the targeted tissue at the target site.
11 . The system of claim 10 , wherein the controller is configured to process the impedance measurement data to calculate an active impedance value during delivery of energy from the one or more electrodes to the targeted tissue.
12 . The system of claim 11 , wherein the controller is configured to process the active impedance value using an algorithm to determine efficacy of ablation/modulation of the targeted tissue based on a comparison of the active impedance value with at least one of a predetermined minimum impedance value, a predetermined low terminal impedance value, and a predetermined high terminal impedance value.
13 . The system of claim 12 , wherein, if the active impedance value is less than the predetermined minimum impedance value, the controller determines that ablation/modulation is unsuccessful and disables energy delivery from the one or more electrodes.
14 . The system of claim 12 , wherein, if the active impedance value is greater than the predetermined minimum impedance value and greater than the predetermined low terminal impedance value, the controller calculates a slope change for the detection of a slope event.
15 . The system of claim 14 , wherein:
if a negative slope event is detected, the controller determines that ablation/modulation is successful and disables energy delivery from the one or more electrodes upon detecting a negative slope event; and
if a negative slope event is not detected, the controller determines that ablation/modulation is unsuccessful and disables energy delivery from the one or more electrodes.
16 . The system of claim 15 , wherein, in the absence of detecting a slope event, the controller determines that ablation/modulation is unsuccessful if the active impedance value is greater than the predetermined high terminal impedance value and disables energy delivery from the one or more electrodes.
17 . The system of claim 1 , wherein the controller is further configured to transmit a signal resulting in an output, via an interactive interface, of an alert to a user indicating a status of the efficacy of ablation/modulation of the targeted tissue.
18 . The system of claim 17 , wherein the alert includes a visual alert comprising at least one of a color and text displayed on a graphical user interface (GUI) and indicating whether the ablation/modulation is successful or unsuccessful.
19 . The system of claim 1 , wherein condition comprises a peripheral neurological condition.
20 . The system of claim 19 , wherein the peripheral neurological condition is associated with a nasal condition or a non-nasal condition of the patient.
21 - 40 . (canceled)